Anti-SARS-CoV immunity induced by a novel CpG oligodeoxynucleotide

To develop CpG oligodeoxynucleotides (CpG ODNs) based therapy for prevention and treatment of severe acute respiratory syndrome (SARS), we selected a novel CpG ODN (BW001), which displays B-type CpG ODN structure feature at the 5′ and A-type CpG ODN structure feature at the 3′, and tested for its an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Musheng, Zhang, Yi, Wan, Min, Dai, Li, Hu, Xiaoping, Wu, Xiuli, Wang, Li, Deng, Ping, Wang, Junzhi, Chen, Jianzhu, Liu, Yongjun, Yu, Yongli, Wang, Liying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2006
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110578/
https://www.ncbi.nlm.nih.gov/pubmed/16298165
http://dx.doi.org/10.1016/j.clim.2005.09.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110578/
https://www.ncbi.nlm.nih.gov/pubmed/16298165
http://dx.doi.org/10.1016/j.clim.2005.09.014

Ejemplares similares